Loading company…
Null Hypothesis develops medical SaaS products that generate medical content and support research and commercialization.
Founded in 2019 and based in Hangzhou, Null Hypothesis develops the KnowS series of virtual medical assistant products, including Express and Competition. Its platform serves pharmaceutical and medical device companies, hospitals, doctors and other medical organizations with academic resources, research support and commercialization tools. In November 2025, the company raised CNY 100 million in Series A funding from Lotus Lake Capital, Growth Investment and Shanghai Zheyu Technology, with participation from Oriza Holdings and other unspecified investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in